Skip to content

Drug interactions

Letermovir + Memantine-donepezil

Severity: Minor

Letermovir and Memantine-donepezil: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir has variable effects on CYP3A, acting as a moderate inhibitor, and may raise donepezil concentrations because donepezil is a CYP3A4 and CYP2D6 substrate. Higher exposure could increase cholinergic effects such as bradycardia, nausea and vomiting.

What this interaction means in plain words

Letermovir and Memantine-donepezil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Letermovir belongs to Anti Virals; Memantine-donepezil belongs to Central Nervous System.

Evidence level: Low

Why it happens

Letermovir inhibition of CYP3A4 may reduce donepezil metabolism.

What to do

No empirical dose change is needed. Monitor for bradycardia, GI intolerance and syncope.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letermovir and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letermovir with Memantine-donepezil?

MediHelp rates the interaction as minor. Letermovir and Memantine-donepezil have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Letermovir has variable effects on CYP3A, acting as a moderate inhibitor, and may raise donepezil concentrations because donepezil is a CYP3A4 and CYP2D6 substrate. Higher exposure could increase cholinergic effects such as bradycardia, nausea and vomiting.

How serious is the interaction between Letermovir and Memantine-donepezil?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Monitor for bradycardia, GI intolerance and syncope.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in